Celgene Settles Revlimid Patent Dispute with Natco Pharma - 24.12.2015

Natco Pharma Ltd and partner Allergan Plc has settled dispute with US-based drug maker Celgene Corp. in the patent infringement case of the latter’s cancer drug Revlimid.

Tags : Natco Pharma Celgene Corp Revlimid Patent

Share :